Zobrazeno 1 - 7
of 7
pro vyhledávání: '"John M. Stacy"'
Publikováno v:
Advances in Rheumatology, Vol 61, Iss 1, Pp 1-6 (2021)
Abstract Background The ACR/EULAR recommendations endorse the use of glucocorticoids (GCs) for rheumatoid arthritis (RA) patients’ flares and as a bridge to a DMARD. However, the recommendation of low dose short-term monotherapy with (GCs) remains
Externí odkaz:
https://doaj.org/article/14409e795dfd48b7850bccf152abe78b
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 9, Pp 507-511 (2020)
Objective Guidelines do not specify how cutoffs for high disease activity differ between the Disease Activity Score 28‐joint count indices DAS28–erythrocyte sedimentation rate (ESR) and DAS28–C‐reactive protein (CRP). Studies that compare DAS
Externí odkaz:
https://doaj.org/article/a1b61d516a294ce28c02375be0899ed9
Publikováno v:
ACR Open Rheumatology
ACR Open Rheumatology, Vol 2, Iss 9, Pp 507-511 (2020)
ACR Open Rheumatology, Vol 2, Iss 9, Pp 507-511 (2020)
Objective Guidelines do not specify how cutoffs for high disease activity differ between the Disease Activity Score 28‐joint count indices DAS28–erythrocyte sedimentation rate (ESR) and DAS28–C‐reactive protein (CRP). Studies that compare DAS
Autor:
John M Stacy, Christopher Tiongson, Larry Burd, Marilyn G. Klug, Katrina Foster, Jacob R. Greenmyer
Publikováno v:
Journal of Addiction Medicine. 14:e64-e69
OBJECTIVES Determine the rates of screening for substance use in pregnant women versus non-pregnant women attending the emergency department (ED). METHODS We captured all ED visits by women of childbearing age (12-50 years in our study) over a 5-year
Publikováno v:
Advances in Rheumatology, Vol 61, Iss 1, Pp 1-6 (2021)
Background The ACR/EULAR recommendations endorse the use of glucocorticoids (GCs) for rheumatoid arthritis (RA) patients’ flares and as a bridge to a DMARD. However, the recommendation of low dose short-term monotherapy with (GCs) remains open to t
Autor:
Prateeti Khazanie, John M. Stacy
Publikováno v:
Circ Heart Fail
BACKGROUND: Due to the high cost of left ventricular assist device (LVAD) therapy, payer type may be an important factor in determining eligibility. How payer type influences outcomes after LVAD implantation is unclear. We therefore aimed to study th
Publikováno v:
Advances in rheumatology (London, England). 61(1)
The ACR/EULAR recommendations endorse the use of glucocorticoids (GCs) for rheumatoid arthritis (RA) patients' flares and as a bridge to a DMARD. However, the recommendation of low dose short-term monotherapy with (GCs) remains open to the discretion